Drawing for NERVUSION

USPTO serial 79067555

NERVUSION

Reviewed by CopyMark Law Group

Reg. 3892601Status 404
Filing date
Status date
Registration date
Dec 21, 2010
Examiner
ELLINGER FATHY, JESSICA M
Law office
MADRID PROCESSING UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NERVUSION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science; unprocessed plastics; adhesives used in industry; gelatine for industrial purposes; collagen and collagen fibers used as a raw ingredient for industrial purposes; gelatine for industrial purposes; protein as a raw material, namely, gelatine and collagen; proteins for making chemicals and used in the manufacture of cosmetic products, pharmaceutical and medical preparations; gelatine glue, gelatine hydrolyses for technical purposesSECTION 71 - CANCELLED—
003Proteins and products, namely, oils, lotions, gels, sprays or ointments for skin or lip use, namely, body oils, body lotions, hair and shower gels, scented body spray and body cream containing protein in solid, liquid or dissolved form as cosmetic products; preparations, namely, non-medicated topical oils, lotions, gels, or ointments, namely, body oils, body lotions, hair and shower gels, scented body spray, body cream, and general purpose mentholated ointment not for medical use, in solid, liquid or dissolved form as end products for use as cosmetics; medicated soaps; all the aforesaid goods included in this class, in particular containing gelatine, collagen and/or cellulose or made on the basis of gelatine, collagen and/or celluloseSECTION 71 - CANCELLED—
005Pharmaceutical preparations for nerve regeneration, nerve transplantation, treatment of nerve injuries, symptoms of paralysis, motion disorders, anastomosis and for the regeneration of neural tissues and veterinary preparations for cattle, horses, dogs, cats and pigs for nerve regeneration, nerve transplantation, treatment of nerve injuries, symptoms of paralysis, motion disorders, anastomosis and for the regeneration of neural tissues; medical plasters; materials for medical dressings; preparations for healing wounds, namely, oils, lotions, gels, and ointments for healing nerve damages and for the regeneration of neural tissues; drug delivery agents in the form of resorbable and absorbable material on the basis of gelatine for internal medical application, namely, sponges, tamponades, fleeces and foils for treating nerve diseases and for the regeneration of neural tissues; drug delivery agents in the form of resorbable and absorbable material on the basis of oxidised cellulose for internal medical application, namely, sponges, tamponades, fleeces and foils for treating nerve diseases and for the regeneration of neural tissues; drug delivery agents in the form of resorbable and absorbable material on the basis of collagen for internal medical application, namely, sponges, tamponades, fleeces and foils for treating nerve diseases and for the regeneration of neural tissues; animal and vegetable proteins, fats and oils in solid or liquid form for making pharmaceutical products and as pharmaceutical product for the treatment of nerve diseases and for the regeneration of neural tissues; biodegradable and biocompatible medical products, namely, sponges, tamponades, fleeces and foils containing gelatine for the regeneration of nerve damage, in particular in tubular form; pharmaceutical and veterinary products, namely, biodegradable and biocompatible preparations containing gelatine for the regeneration of nerve damage, in particular in tubular form; biodegradable and biocompatible material containing gelatine, in particular in tubular form, for internal medical application, in particular for the regeneration of nerve damage; pharmaceutical preparations, namely, medicated oils, lotions, gels, or ointments for the relief of symptoms caused by shingles, diabetes, and for treatment of wounds, in solid, liquid or dissolved form; all the afore-mentioned goods in this class not for external application, in particular, not for dermal applicationSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 23, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 23, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 27, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 2, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 2, 2018INPCINVALIDATION PROCESSED—
Mar 28, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 28, 2017C71TCANCELLED SECTION 71—
Dec 10, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 18, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 5, 2012LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 11, 2012LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 15, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 15, 2011FIMPFINAL DISPOSITION PROCESSED—
Mar 21, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 21, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 23, 2010OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 7, 2010OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 7, 2010OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 5, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 5, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 30, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 28, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Aug 20, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 20, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 20, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 17, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 17, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 17, 2010ALIEASSIGNED TO LIE—
Jul 6, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 12, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 29, 2010CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 29, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 30, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 30, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2009ALIEASSIGNED TO LIE—
Nov 16, 2009MAILPAPER RECEIVED—
Jun 12, 2009RFNTREFUSAL PROCESSED BY IB—
May 20, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 20, 2009RFRRREFUSAL PROCESSED BY MPU—
May 20, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 19, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2009RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
May 18, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 17, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
May 8, 2009DOCKASSIGNED TO EXAMINER—
May 8, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2009LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
May 7, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance